Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 23.


Tuekprakhon, Aekkachai, Nutalai, Rungtiwa, Dijokaite-Guraliuc, Aiste, Zhou, Daming, Ginn, Helen M, Selvaraj, Muneeswaran, Liu, Chang, Mentzer, Alexander J, Supasa, Piyada, Duyvesteyn, Helen ME
et al (show 26 more authors) (2022) Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. CELL, 185 (14). 2422-+.


Neale, Isabel, Ali, Mohammad, Kronsteiner, Barbara, Longet, Stephanie, Abraham, Priyanka, Deeks, Alexandra S, Brown, Anthony, Moore, Shona C ORCID: 0000-0001-8610-2806, Stafford, Lizzie, Dobson, Susan L ORCID: 0000-0002-4958-0021
et al (show 21 more authors) (2023) CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study. mBio, 14 (5). e0121223-e0121223.


Tedder, Richard, Parker, Eleanor, Sureda-Vives, Macià, Fernandez, Natalia, Randell, Paul, Marchesin, Federica, Katsanovskaja, Ksenia, Harvey, Ruth, Lilley, Alice, Harris, Benjamin HL
et al (show 27 more authors) (2021) Detection and Quantification of Antibody to SARS-CoV-2 Receptor Binding Domain Provides Enhanced Sensitivity, Specificity and Utility. [Preprint]


Rosadas, Carolina, Khan, Maryam, Parker, Eleanor, Marchesin, Federica, Katsanovskaja, Ksenia, Sureda-Vives, Macia, Fernandez, Natalia, Randell, Paul, Harvey, Ruth, Lilley, Alice
et al (show 28 more authors) (2022) Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility. JOURNAL OF VIROLOGICAL METHODS, 302. 114475-.


Tomic, Adriana, Skelly, Donal T, Ogbe, Ane, O'Connor, Daniel, Pace, Matthew, Adland, Emily, Alexander, Frances, Ali, Mohammad, Allott, Kirk, Ansari, M Azim
et al (show 53 more authors) (2022) Divergent trajectories of antiviral memory after SARS-CoV-2 infection. NATURE COMMUNICATIONS, 13 (1). 1251-.


Emary, Katherine RW, Golubchik, Tanya, Aley, Parvinder K, Ariani, Cristina V, Angus, Brian, Bibi, Sagida, Blane, Beth, Bonsall, David, Cicconi, Paola, Charlton, Sue
et al (show 57 more authors) (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. LANCET, 397 (10282). pp. 1351-1362.


Moore, Shona ORCID: 0000-0001-8610-2806, Kronsteiner, Barbara, Longet, Stephanie, Adele, Sandra, Deeks, Alexandra, Liu, Chang, Dejnirattisai, Wanwisa, Silva Reyes, Laura, Meardon, Naomi, Faustini, Sian
et al (show 54 more authors) (2023) Evolution of Long-Term Hybrid Immunity in Healthcare Workers after Different Covid-19 Vaccination Regimens: A Longitudinal Observational Cohort Study. Med, 4 (3). 191-215.e9.


Moore, Shona C ORCID: 0000-0001-8610-2806, Kronsteiner, Barbara, Longet, Stephanie, Adele, Sandra, Deeks, Alexandra S, Liu, Chang, Dejnirattisai, Wanwisa, Reyes, Laura Silva, Meardon, Naomi, Faustini, Sian
et al (show 55 more authors) (2023) Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens. MED, 4 (3). 191-+.


McNaughton, Anna, Paton, Robert, Edmans, Matthew, Youngs, Jonathan, Wellens, Judith, Phalora, Prabhjeet, Fyfe, Alex, Belij-Rammerstorfer, Sandra, Bolton, Jai, Ball, Jonathan
et al (show 47 more authors) (2021) Fatal COVID-19 Outcomes are Associated with an Antibody Response Targeting Epitopes Shared with Endemic Coronaviruses. [Preprint]


McNaughton, Anna, Paton, Robert, Edmans, Matthew, Youngs, Jonathan, Wellens, Judith, Phalora, Prabhjeet, Fyfe, Alex, Belij-Rammerstorfer, Sandra, Bolton, Jai, Ball, Jonathan
et al (show 47 more authors) (2021) Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses. [Preprint]


McNaughton, Anna L, Paton, Robert S, Edmans, Matthew, Youngs, Jonathan, Wellens, Judith, Phalora, Prabhjeet, Fyfe, Alex, Belij-Rammerstorfer, Sandra, Bolton, Jai S, Ball, Jonathan
et al (show 44 more authors) (2022) Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses. JCI INSIGHT, 7 (13). e156372-.


Puksuriwong, Suttida, Ahmed, Muhammad S ORCID: 0000-0001-6163-8102, Sharma, Ravi, Krishnan, Madhan, Leong, Sam, Lambe, Teresa, McNamara, Paul S ORCID: 0000-0002-7055-6034, Gilbert, Sarah C and Zhang, Qibo
(2020) Modified Vaccinia Ankara–Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid Tissue. The Journal of infectious diseases, 222 (5). pp. 807-819.


Hornsby, Hailey, Nicols, Alexander R, Longet, Stephanie, Liu, Chang, Tomic, Adriana, Angyal, Adrienn, Kronsteiner, Barbara, Tyerman, Jessica K, Tipton, Tom, Zhang, Peijun
et al (show 34 more authors) (2023) Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history. Nature communications, 14 (1). p. 5065.


Dejnirattisai, Wanwisa, Huo, Jiandong, Zhou, Daming, Zahradník, Jiří, Supasa, Piyada, Liu, Chang, Duyvesteyn, Helen ME, Ginn, Helen M, Mentzer, Alexander J, Tuekprakhon, Aekkachai
et al (show 63 more authors) (2021) Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. bioRxiv, 3 (01-03). 2021.12.03.471045-.


Liu, Xinxue, Wright, Annie, Feng, Shuo, Janani, Leila, Aley, Parvinder K, Babbage, Gavin, Baker, Jonathan, Baxter, David, Bawa, Tanveer, Bula, Marcin
et al (show 50 more authors) (2023) Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial. JOURNAL OF INFECTION, 87 (1). pp. 18-26.


Liu, Xinxue, Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna
et al (show 48 more authors) (2022) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. JOURNAL OF INFECTION, 84 (6). pp. 795-813.


Liu, Xinxue, Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna
et al (show 48 more authors) (2023) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial (vol 84, pg 795, 2022). JOURNAL OF INFECTION, 86 (5). pp. 540-541.


Nutalai, Rungtiwa, Zhou, Daming, Tuekprakhon, Aekkachai, Ginn, Helen M, Supasa, Piyada, Liu, Chang, Huo, Jiandong, Mentzer, Alexander J, Duyvesteyn, Helen ME, Dijokaite-Guraliuc, Aiste
et al (show 25 more authors) (2022) Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. CELL, 185 (12). 2116-+.


Dejnirattisai, Wanwisa, Huo, Jiandong, Zhou, Daming, Zahradník, Jiří, Supasa, Piyada, Liu, Chang, Duyvesteyn, Helen ME, Ginn, Helen M, Mentzer, Alexander J, Tuekprakhon, Aekkachai
et al (show 63 more authors) (2022) SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell, 185 (3). 467-484.e15.


Munro, Alasdair PS, Janani, Leila, Cornelius, Victoria, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna, Dodd, Kate
et al (show 44 more authors) (2021) Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. LANCET, 398 (10318). pp. 2258-2276.


Folegatti, Pedro M, Ewer, Katie J, Aley, Parvinder K, Angus, Brian, Becker, Stephan, Belij-Rammerstorfer, Sandra, Bellamy, Duncan, Bibi, Sagida, Bittaye, Mustapha, Clutterbuck, Elizabeth A
et al (show 22 more authors) (2020) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. LANCET, 396 (10249). pp. 467-478.


Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Cornelius, Victoria, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna
et al (show 45 more authors) (2022) Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. LANCET INFECTIOUS DISEASES, 22 (8). pp. 1131-1141.


Ogbe, Ane, Kronsteiner, Barbara, Skelly, Donal T, Pace, Matthew, Brown, Anthony, Adland, Emily, Adair, Kareena ORCID: 0000-0001-9884-2094, Akhter, Hossain Delowar, Ali, Mohammad, Ali, Serat-E ORCID: 0000-0002-9806-8796
et al (show 70 more authors) (2021) T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. NATURE COMMUNICATIONS, 12 (1). 2055-.

This list was generated on Mon Mar 18 17:09:33 2024 GMT.